Where does 4D Pharma Research Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), 4D Pharma Research Limited ranks #6,731 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does 4D Pharma Research Limited hold?

4D Pharma Research Limited holds 49 US utility patents granted between 2016 and 2023, spanning 11 technology areas.

What is 4D Pharma Research Limited's Innovation Score?

4D Pharma Research Limited has an Innovation Score of 38.8 out of 100 (top 40% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does 4D Pharma Research Limited focus on?

4D Pharma Research Limited's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 47 patents, ranking #383 of 6,058 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

Is 4D Pharma Research Limited's patent grant rate increasing or decreasing?

4D Pharma Research Limited's recent grant velocity is +33% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for 4D Pharma Research Limited's patents?

4D Pharma Research Limited's patents average 17.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the 4D Pharma Research Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

4D Pharma Research Limited

USPTO PatentsView assignee record - 49 granted patents across 11 technology areas, recorded in grant years 2016–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, 4D ranks #6,731 of 49,997 tracked US assignees by granted-patent volume, with 49 patents across 11 technology areas.

#6,731
of 49,997 US assignees by volume: Top 40%
by Innovation Score (38.8/100): 17.3
avg claims per patent: +33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6731 · Foreign Corporation #6,731 · 49 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 49 grants
UPPER-Q #6,731/49,997
PHOTO-FINISH Agfa Graphics
CPC-FOCUS A61P · 11 areas
INNOV-THIN 38.8/100
CLAIMS-RICH 17.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +33% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Agfa Graphics NV (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How 4D’s 38.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.5 pts (35%) Velocity 3.2 pts (8%) Breadth 11.7 pts (30%) Claim depth 10.4 pts (27%)

Qualcomm Incorporated · highest

85
4D Pharma Research · this assignee

39
Aerie Pharmaceuticals · near

39
DPG USA · near

39
Oy Halton Group · near

39
Webroot · near

39
3D Lighting… · lowest

7

What this shows 4D's Innovation Score is 38.8/100 (top 40% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for 4D?

Each dot is one of 4D’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). 4D’s own 17.3 claims/patent is ABOVE the 15.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

4D vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where 4D's grants concentrate

4D Pharma Research Limited is a focused PatentsView assignee: 11 CPC subclasses with 95.9% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2019 (12 grants) versus a trough of 1 in 2016. By volume, 4D sits between Wichita State University and Andritz OY.

4D's three-year grant acceleration

From 2019–2021 to 2022–2024, 4D Pharma Research Limited moved from 27 to 13 grants (0.48x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Wichita State Uni…

50
inmusic Brands

50
medmix Switzerland

50
varmour Networks

50
A L M T

49
Agfa Graphics

49
Agjunction

49
Andritz OY

49
4D Pharma Research ◀

49

What this shows 4D holds 49 patents at rank #6,731, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near 4D

By rank, the assignees closest to #6,731 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in 4D's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for 4D, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), 4D ranks #383 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (39 here).

Oy Halton Group Ltd. 39 Aerie Pharmaceuticals, Inc. 39 Webroot Inc. 39 DPG USA Inc. 39

4D's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 40% higher than 60% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

4D Pharma Research Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	2.0%
2017	3	6.1%
2018	5	10.2%
2019	12	24.5%
2020	7	14.3%
2021	8	16.3%
2022	12	24.5%
2023	1	2.0%

Which technologies does 4D Pharma Research Limited patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 47

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 47

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 33

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 31

C12R - Indexing Scheme Associated With Subclasses C12c - C12q, Relating TO Microorganisms 27

A23V - Indexing Scheme Relating TO Foods, Foodstuffs OR Non-alcoholic Beverages AND Lactic OR Propionic Acid Bacteria Used IN Foodstuffs OR Food Preparation 26

Y02A - Technologies FOR Adaptation TO Climate Change 24

A23C - Dairy Products, e.g. Milk, Butter OR CHEESE; Milk OR Cheese SUBSTITUTES; Making OR Treatment Thereof 13

A23K - Fodder 7

C07K - Peptides 5

A23P - Shaping OR Working OF Foodstuffs, NOT Fully Covered BY A Single Other Subclass 3

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

4D Pharma Research Limited's patent record in context - here's where to go next.

4D Pharma Research Limited's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 95.9% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #6,731 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare 4D Pharma Research Limited against Wichita State University, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.